The problem down in Brazil is not that the drug companies are charging too much for AIDS drugs. The problem is that Brazil is refusing to budget sufficient money to cover the costs associated with dealing with the AIDS problem the country is sadly faced with. Instead they're simply robbing drug companies. The large drug manufacturing consortium should consider a boycott on Brazil over the complete range of the rest of their drug products or simply don't send any of the newer drugs as they enter the market down there so Brazil can't steal them too.
The idea that drug companies be offered a 'reward' instead of letting market price be tied to R&D is a bad one. Say what you will about the evils of capitalism, but the one truth remains that individuals and companies will produce more (to the benefit of the community at large) when they can anticipate a greater benefit to themselves for doing so. Finding good drugs that cure nasty diseases is expensive no matter how you look at it. Governments are neither willing nor able to spend the necessary money. The only way that private enterprise is going to step up and do this is if it pays them extremely well. I for one would like to see the day where one of these big companies find a final cure for AIDS and cancer. It's just unfortunate that no more reasonable alternative to that end exists. Regards, John S. > Date: Fri, 11 May 2007 13:04:33 -0100 > From: nettime's_busy_reader <[EMAIL PROTECTED]> > Subject: <nettime> Brazil puts patients before patents > > http://www.huffingtonpost.com/james-love/brazil-puts-patients-befo_b_47651.html > > May 4, 2007 > The Huffington Post > James Love > > Brazil puts patients before patents, rejects Bush administration > pressure and issues compulsory license on important AIDS drug <...> # distributed via <nettime>: no commercial use without permission # <nettime> is a moderated mailing list for net criticism, # collaborative text filtering and cultural politics of the nets # more info: [EMAIL PROTECTED] and "info nettime-l" in the msg body # archive: http://www.nettime.org contact: [EMAIL PROTECTED]